Rating History for Definium Therapeutics Inc (DFTX) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for DFTX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/8/2026 David Amsellem Maintain Overweight
(N/A)		 48.00
(49.00)		  
 		   Details